{"id":"https://openalex.org/W4200219012","doi":"https://doi.org/10.1016/j.annonc.2021.10.142","title":"123MO Monalizumab, cetuximab and durvalumab in first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): A phase II trial","display_name":"123MO Monalizumab, cetuximab and durvalumab in first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): A phase II trial","publication_year":2021,"publication_date":"2021-12-01","ids":{"openalex":"https://openalex.org/W4200219012","doi":"https://doi.org/10.1016/j.annonc.2021.10.142"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2021.10.142","doi":"https://doi.org/10.1016/j.annonc.2021.10.142","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.10.142","pdf_url":"http://www.annalsofoncology.org/article/S0923753421046780/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.annalsofoncology.org/article/S0923753421046780/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002590653","display_name":"Dimitrios Colevas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D.A. Colevas","raw_affiliation_strings":["Medical Oncology, Stanford Cancer Center, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Stanford Cancer Center, Stanford, CA, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041561535","display_name":"Krzysztof J. Misiukiewicz","orcid":"https://orcid.org/0000-0001-9500-1484","observed_orcids":["https://orcid.org/0000-0001-9500-1484"]},"institutions":[{"id":"https://openalex.org/I1324220072","display_name":"Mount Sinai Hospital","ror":"https://ror.org/01zkyz108","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1320796813","https://openalex.org/I1324220072"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Misiukiewicz","raw_affiliation_strings":["Medical Oncology, Mount Sinai Hospital, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Mount Sinai Hospital, New York, NY, USA","institution_ids":["https://openalex.org/I1324220072"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031626209","display_name":"Alexander T. Pearson","orcid":"https://orcid.org/0000-0003-2801-7456","observed_orcids":["https://orcid.org/0000-0003-2801-7456"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A.T. Pearson","raw_affiliation_strings":["Medical Oncology, The University of Chicago, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, The University of Chicago, Chicago, IL, USA","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028065894","display_name":"J\u00e9r\u00f4me Fayette","orcid":"https://orcid.org/0000-0002-8126-7019","observed_orcids":["https://orcid.org/0000-0002-8126-7019","https://orcid.org/0000-0003-4126-1664"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. Fayette","raw_affiliation_strings":["Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017176613","display_name":"Jessica Ruth Bauman","orcid":"https://orcid.org/0000-0001-8691-0387","observed_orcids":["https://orcid.org/0000-0001-8691-0387"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.R. Bauman","raw_affiliation_strings":["Department of Hematology-Oncology, Fox Chase Cancer Center - Main Campus, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology-Oncology, Fox Chase Cancer Center - Main Campus, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085647218","display_name":"Didier Cupissol","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154388","display_name":"Institut Regional du Cancer de Montpellier","ror":"https://ror.org/02693j602","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925","https://openalex.org/I4387154388"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D. Cupissol","raw_affiliation_strings":["Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France","institution_ids":["https://openalex.org/I4387154388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108780490","display_name":"Esma Sa\u00e2da-Bouzid","orcid":"https://orcid.org/0009-0002-3924-286X","observed_orcids":["https://orcid.org/0009-0002-3924-286X"]},"institutions":[{"id":"https://openalex.org/I4210151846","display_name":"Centre Antoine Lacassagne","ror":"https://ror.org/05hmfw828","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210151846"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Saada-Bouzid","raw_affiliation_strings":["Medical Oncology, Centre Antoine Lacassagne, Nice, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Centre Antoine Lacassagne, Nice, France","institution_ids":["https://openalex.org/I4210151846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064319129","display_name":"Douglas R. Adkins","orcid":"https://orcid.org/0000-0003-3207-8227","observed_orcids":["https://orcid.org/0000-0003-3207-8227"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D.R. Adkins","raw_affiliation_strings":["Medical Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057847598","display_name":"Delphine Marie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D.B. Marie","raw_affiliation_strings":["Research and Development, Innate Pharma, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Innate Pharma, Marseille, France","institution_ids":["https://openalex.org/I4210143497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081121575","display_name":"St\u00e9phanie Cornen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"S.L. Cornen","raw_affiliation_strings":["Research and Development, Innate Pharma, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Innate Pharma, Marseille, France","institution_ids":["https://openalex.org/I4210143497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111727216","display_name":"Pascale Andr\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Andr\u00e9","raw_affiliation_strings":["Research and Development, Innate Pharma, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Innate Pharma, Marseille, France","institution_ids":["https://openalex.org/I4210143497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015916808","display_name":"Florent Carrette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F. Carrette","raw_affiliation_strings":["Research and Development, Innate Pharma, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Innate Pharma, Marseille, France","institution_ids":["https://openalex.org/I4210143497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038610822","display_name":"Federico Rotolo","orcid":"https://orcid.org/0000-0003-4837-6501","observed_orcids":["https://orcid.org/0000-0003-4837-6501"]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F. Rotolo","raw_affiliation_strings":["Research and Development, Innate Pharma, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Innate Pharma, Marseille, France","institution_ids":["https://openalex.org/I4210143497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112745653","display_name":"Agnes Boyer Chammard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Boyer Chammard","raw_affiliation_strings":["Research and Development, Innate Pharma, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Innate Pharma, Marseille, France","institution_ids":["https://openalex.org/I4210143497"]}]},{"author_position":"last","author":{"id":null,"display_name":"R.B. Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.B. Cohen","raw_affiliation_strings":["Center for Head and Neck Cancer, Abramson Cancer Center, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Head and Neck Cancer, Abramson Cancer Center, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4390039297"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.9877,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":{"value":0.79356867,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":98},"biblio":{"volume":"32","issue":null,"first_page":"S1432","last_page":"S1432"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6240000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6240000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.36959999799728394,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monalizumab","display_name":"monalizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9430000185966492},{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":1.0},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9129999876022339},{"id":"https://openalex.org/keywords/recurrent-or-metastatic-disease","display_name":"recurrent or metastatic disease","score":0.8610000014305115},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8539999723434448},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8880000114440918},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8389999866485596},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7300000190734863},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.7730000019073486}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9404830932617188},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.8860759139060974},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.8322525024414062},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6522251963615417},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5920595526695251},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.46897730231285095},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.44633328914642334},{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.4336891174316406},{"id":"https://openalex.org/C2778650287","wikidata":"https://www.wikidata.org/wiki/Q7838098","display_name":"Tremelimumab","level":5,"score":0.4253832995891571},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.419497013092041},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.36599138379096985},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.3506845533847809},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3468095660209656},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2900734841823578},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.26727986335754395},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.23788252472877502},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.20307433605194092},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.08726173639297485},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.05680656433105469}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2021.10.142","doi":"https://doi.org/10.1016/j.annonc.2021.10.142","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.10.142","pdf_url":"http://www.annalsofoncology.org/article/S0923753421046780/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2021.10.142","doi":"https://doi.org/10.1016/j.annonc.2021.10.142","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.10.142","pdf_url":"http://www.annalsofoncology.org/article/S0923753421046780/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200219012.pdf","grobid_xml":"https://content.openalex.org/works/W4200219012.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3110675926","https://openalex.org/W2978568563","https://openalex.org/W2897892714","https://openalex.org/W2885785537","https://openalex.org/W2740680022","https://openalex.org/W4387811178","https://openalex.org/W4410015137","https://openalex.org/W3032062778","https://openalex.org/W7070236501","https://openalex.org/W3205998216"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2021-12-31T00:00:00"}